Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesFour potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas
International Journal of Cancer, 08/20/08
Partheen K et al. - In a trial to assess the gene and protein expressions for 7 potential biomarkers, to determine if it is possible to use them as prognostic factors, it was determined that the 4 biomarkers CLU, ITGB3, PRAME and CAPG may be used as prognostic factors for pts with stage III serous ovarian adenocarcinomas
Methods- Genes selected from a previous microarray analysis, CLU, ITGB3, TACC1, MUC5B, CAPG, PRAME and TROAP, were analyzed in 19 of the tumors with quantitative real-time polymerase chain reaction
- Protein expressions of CLU, ITGB3, PRAME and CAPG were analyzed in 43 of the tumors with western blot for semiquantitative analysis
- Immunohistochemistry was used to localize expression of the proteins in tumor samples
- CLU and ITGB3 were more expressed in tumors from survivors and PRAME and CAPG were more expressed in tumors from deceased pts
- None of the other 3 genes were significantly differently expressed
- The mRNA and protein expressions correlated and all 4 proteins were significantly differently expressed
| Previous Article | Next Article |
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update: Endometrial Cancer
OBG Management, 07/02/09
Sentinel lymph node sampling in gynaecological cancers: Techniques and clinical applications
European Journal of Surgical Oncology, 06/05/09
Surveillance of patients after initial treatment of ovarian cancer
Critical Reviews in Oncology/Hematology, 06/11/09
Sponsor
Article Search
Sponsor